In mid-June 2026, autonomous driving company MINIEYE (2431.HK) issued two consecutive voluntary announcements, capturing significant market attention. The first, on June 9th, announced the signing of a procurement contract involving over a hundred autonomous buses with a total value exceeding 130 million Chinese yuan. This was followed on June 11th by the disclosure of a strategic cooperation agreement with robotics company LDROBOT (1236.HK), marking a joint foray into the field of physical AI.
The sequential release of these announcements has undoubtedly injected a new commercial narrative into a company long shadowed by operational losses and a depressed share price. However, behind the optimism of a confirmed order and the catalyst of AI concepts, the company's heavy financial burden and challenging commercialization path remain the key variables determining its long-term value.
A Tangible Order for 100 Units
On June 9th, MINIEYE released a voluntary announcement stating it had signed an autonomous vehicle procurement contract with an independent third party focused on smart vehicles and intelligent transportation. According to the contract, MINIEYE will supply autonomous buses, autonomous driving kits, and related technical services. The total contract value, including tax, exceeds 130 million yuan and involves the procurement of over a hundred autonomous buses. The products are intended primarily for applications in local tourism, micro-circulation transit, and public bus scenarios.
This represents the most tangible progress in commercialization since the company announced its strategic focus on L4-level unmanned logistics vehicles in November 2024. A batch order of this scale signifies that MINIEYE's autonomous vehicle business is transitioning from "proof-of-concept" to "scaled delivery." For a company yet to achieve profitability, the signaling effect is significant.
Cross-Industry Alliance to Pursue the Physical AI Trend
Just two days later, on June 11th, MINIEYE announced again, this time disclosing a strategic cooperation agreement with Shenzhen LDROBOT Co., Ltd. The two parties will collaborate on co-creating physical AI technology, enabling full-scenario deployment, and empowering the industrial ecosystem. This includes jointly researching and developing end-to-end unmanned solutions combining "unmanned vehicles + robots," and co-creating robot products with "emotional value" as a core output.
The leap from autonomous driving to the robotics sector has sparked considerable market imagination. Since 2025, the robotics segment in the Hong Kong stock market has continued to gain momentum, becoming one of the core hotspots for capital. Whether this cooperation can open new narrative space for the company's long-term valuation is a key focus for the secondary market.
2025 Loss Widens Nearly 85% Year-on-Year; Operating Cash Flow Remains Heavily Negative
However, shifting focus back to fundamentals reveals that MINIEYE's financial foundation remains strained.
In 2025, the company achieved operating revenue of 760 million yuan, representing a year-on-year increase of approximately 16.0%. This growth rate has significantly decelerated compared to 37.4% in 2024 and 70.5% in 2023. More critically, the company's net loss attributable to shareholders for the year reached 400 million yuan, an 84.8% widening of the loss compared to the previous year. Cumulative losses over five years have surpassed 1.1 billion yuan.
The losses stem from high research and development expenditures and a prolonged commercialization cycle. In 2025, R&D expenses amounted to 330 million yuan, accounting for 43.8% of revenue—a substantial burden for a company with annual revenue under 800 million yuan. Although gross margin has been improving consistently, rising from 9.7% in 2021 to 18.6% in 2025, profitability remains elusive in the face of high R&D and sales costs.
Regarding cash flow, the company's "cash-burning" state persists. In 2025, net cash outflow from operating activities was as high as 420 million yuan, and the year-end cash balance decreased to 690 million yuan. Following two share placements earlier in the year that raised approximately 370 million Hong Kong dollars in total, these funds are being consumed rapidly.
Order Boosts Revenue Outlook, But Path to Profitability Remains Long
The procurement contract exceeding 130 million yuan represents a concrete commercial achievement for MINIEYE. Even assuming the contract revenue is recognized over the next two years (e.g., with deliveries commencing gradually in the second half of 2026), this order is still expected to provide a positive boost to revenue for 2026-2027.
According to institutional financial forecasts, the company's full-year 2026 revenue is estimated at 1.35 billion yuan (a 78.2% year-on-year increase), with 2027 revenue projected at 2.26 billion yuan (a 66.8% increase). These forecasts also anticipate a narrowing of losses or even the first breakeven/profitability in 2027. The signing of the hundred-unit order lends more realistic support to these revenue projections. However, it's important to note that the 130 million yuan contract value still represents a limited proportion relative to the projected revenue scale. The company's ability to secure similar or larger orders consistently will be crucial to fulfilling these high-growth expectations.
Balancing Order Catalyst Against Lock-up Expiry Pressure
In terms of share price performance, MINIEYE's latest market capitalization is approximately 4.2 billion Hong Kong dollars, with a closing price of 10.1 HKD per share. This represents a 40.6% decline from its IPO issue price and a drop of over 70% from its peak in March 2025. If the share price remains depressed, the market will also monitor whether its total market capitalization can stay above the threshold for inclusion in the Southbound Stock Connect. The signing of this order and the strategic cooperation are expected to provide some near-term support for the share price, attracting thematic investment interest. However, from a medium-to-long-term perspective, the core variable for whether the share price can stabilize and emerge from its current difficulties will be the company's ability to consistently deliver commercialization results that exceed expectations, matching its anticipated explosive revenue growth.
Comments